About HeartSciences
We're on a mission to transform cardiovascular care through AI-powered early detection, making advanced cardiac diagnostics accessible at the point of care.
Our Mission
Cardiovascular disease remains the leading cause of death globally, often because critical conditions go undetected until it's too late. Traditional ECG interpretation misses subtle signs that could enable earlier intervention.
HeartSciences was founded to change that. By combining advanced AI algorithms with clinical-grade ECG acquisition, we're enabling healthcare providers to detect cardiac abnormalities earlier than ever before.
Our technology is the result of years of research, rigorous clinical validation, and collaboration with leading healthcare institutions around the world.
Mission Image
Our Values
Patient First
Everything we do is guided by our commitment to improving patient outcomes.
Scientific Rigor
Our technology is built on a foundation of peer-reviewed clinical research.
Integrity
We maintain the highest standards of ethics in everything we do.
Innovation
We continuously push the boundaries of what AI can achieve in healthcare.
Leadership Team
Our team brings together expertise in AI, cardiology, medical devices, and healthcare innovation.
Dr. Mark Anderson
Chief Executive Officer
Former cardiology professor with 20+ years in medical device innovation.
Dr. Sarah Chen
Chief Medical Officer
Board-certified cardiologist and AI researcher from Stanford.
Michael Rodriguez
Chief Technology Officer
Former Google Health engineer specializing in medical AI systems.
Jennifer Williams
Chief Commercial Officer
15 years scaling healthcare technology companies globally.
Company Milestones
Company Founded
HeartSciences established with a mission to transform cardiac diagnostics.
First Algorithm
Development of initial AI algorithm for diastolic dysfunction detection.
Clinical Trials
Multi-center clinical validation studies initiated across 12 medical centers.
FDA Clearance
Received 510(k) clearance for MyoVista Insights software.
Commercial Launch
Full commercial availability in the United States.
International Expansion
CE marking obtained, expansion into European markets.
Algorithm Expansion
Enhanced clearance for 12+ cardiac condition detection algorithms.
Schedule Your Demo Today
See how HeartSciences can transform cardiovascular care at your institution. Our team will walk you through the platform and answer all your questions.
Request a Demo
By submitting, you agree to our Privacy Policy.